These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6453413)

  • 1. Current status of nitrosoureas under development in Japan.
    Ogawa M; Fujimoto S
    Recent Results Cancer Res; 1981; 76():115-24. PubMed ID: 6453413
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I study of GANU and MCNU.
    Ogawa M
    Cancer Treat Rev; 1980 Dec; 7(4):197-203. PubMed ID: 6452200
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor activity of a nitrosourea derivative, CNUA, on murine tumors.
    Edanami K; Komiyama K; Kuroda T; Umezawa I
    Cancer Chemother Pharmacol; 1984; 13(1):22-6. PubMed ID: 6234104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
    Kato T; Ota K
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):502-5. PubMed ID: 2949703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
    Harada K; Kiya K; Okamoto H; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1017-23. PubMed ID: 6172720
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
    Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
    Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP; Montgomery JA
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract]   [Full Text] [Related]  

  • 8. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
    Sava G; Giraldi T
    Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of chlorozotocin (NSC-178748).
    Ungerleider RS
    Cancer Treat Rev; 1980 Dec; 7(4):191-5. PubMed ID: 6452199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
    Wakui A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1327-38. PubMed ID: 6223595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II study of 3 new nitrosoureas, 1 American (chlorozotocin) and 2 French (RFCNU and RPCNU)].
    Mathé G; Schein PS; De Vassal F; Serrou B; Imbach JL
    Sem Hop; 1982 Sep; 58(33):1867-71. PubMed ID: 6293062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Different sensitivity of DNA synthesis in normal and tumor cells to exposure to several N-alkyl-N-nitrosoureas].
    Sokolova IS; Kukushkina GV; Gorbacheva LB
    Dokl Akad Nauk SSSR; 1979; 245(1):260-4. PubMed ID: 155515
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary study of the effects of vitamin A on antineoplastic activities of chemotherapeutic agents in glioma.
    Tani E; Morimura T; Kaba K; Itagaki T
    Neurol Med Chir (Tokyo); 1980 Jul; 20(7):665-77. PubMed ID: 6160411
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances on ACNU in the past 10 years].
    Niitani H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):727-31. PubMed ID: 3281592
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung.
    Saijo N; Niitani H
    Cancer Chemother Pharmacol; 1980; 4(3):165-71. PubMed ID: 6249513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical evaluation of analogues, IV. Nitrosoureas.
    Carter SK
    Recent Results Cancer Res; 1980; 70():119-23. PubMed ID: 7355243
    [No Abstract]   [Full Text] [Related]  

  • 18. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationships in anticancer agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carcinoma.
    Montgomery JA; Mayo JG
    J Med Chem; 1974 May; 17(5):477-80. PubMed ID: 4830248
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical comparison of the nitrosoureas.
    Wasserman TH; Slavik M; Carter SK
    Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.